An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share comparison images, injection guides and claims of next-day British shipping. Sellers promote the substance there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to individuals injecting products of uncertain source.
Several experts said the popularity for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, risking fines, prosecution or imprisonment.
Service Response and Content Removal
Based on TikTok, the platform has removed problematic content and banned related hashtags and search suggestions. The organization said it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Digital Trading Operations
Research also found communities with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of users, populated with images of slimming results, positive reviews and step-by-step guides for preparing or administering at residence.
Within minutes of entering one group, a seller shared contact information, where most transactions occur. The seller provided an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, medical conditions or past usage.
Item Details and Pricing
Inside these groups, posts show black plastic parcels with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram said it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting substances they can’t verify. Although the science behind this drug is valid, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.
Her staff has previously seen individuals injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to potentially significant health risks”.
